-+ 0.00%
-+ 0.00%
-+ 0.00%

JMP Securities Reiterates Market Outperform on Sana Biotechnology, Maintains $5 Price Target

Benzinga·06/24/2025 13:45:26
Listen to the news
JMP Securities analyst Reni Benjamin reiterates Sana Biotechnology (NASDAQ:SANA) with a Market Outperform and maintains $5 price target.